The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Axcella Health Inc | COM | 05454B105 | 8,708,219 | 18,142,125 | SH | DFND | 2,3 | 0 | 18,142,125 | 0 | |
Axcella Health Inc | COM | 05454B105 | 5,332,521 | 11,109,420 | SH | DFND | 3 | 0 | 11,109,420 | 0 | |
Codiak Biosciences Inc | COM | 192010106 | 533,043 | 3,054,687 | SH | DFND | 1,3 | 0 | 3,054,687 | 0 | |
Codiak Biosciences Inc | COM | 192010106 | 84,798 | 485,949 | SH | DFND | 3 | 0 | 485,949 | 0 | |
Denali Therapeutics Inc | COM | 24823R105 | 60,364,063 | 2,619,968 | SH | DFND | 1,3 | 0 | 2,619,968 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 1,836,394 | 10,162,664 | SH | DFND | 2,3 | 0 | 10,162,664 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 1,844,095 | 10,205,282 | SH | DFND | 1,3 | 0 | 10,205,282 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 5,431,730 | 30,059,382 | SH | DFND | 3 | 0 | 30,059,382 | 0 | |
Foghorn Therapeutics Inc | COM | 344174107 | 57,851,444 | 9,330,878 | SH | DFND | 1,3 | 0 | 9,330,878 | 0 | |
Foghorn Therapeutics Inc | COM | 344174107 | 20,728,100 | 3,343,242 | SH | DFND | 3 | 0 | 3,343,242 | 0 | |
Moderna Inc | COM | 60770K107 | 1,978,543,342 | 12,882,819 | SH | DFND | 2,3 | 0 | 12,882,819 | 0 | |
Moderna Inc | COM | 60770K107 | 602,648 | 3,924 | SH | DFND | 3 | 0 | 3,924 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 42,118,682 | 6,984,856 | SH | DFND | 1,3 | 0 | 6,984,856 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 134,111,560 | 22,240,723 | SH | DFND | 3 | 0 | 22,240,723 | 0 | |
Sana Biotechnology Inc | COM | 799566104 | 42,747,304 | 13,072,570 | SH | DFND | 1,3 | 0 | 13,072,570 | 0 | |
Sana Biotechnology Inc | COM | 799566104 | 69,214,285 | 21,166,448 | SH | DFND | 3 | 0 | 21,166,448 | 0 | |
Seres Therapeutics Inc | COM | 81750R102 | 47,927,807 | 8,452,876 | SH | DFND | 2,3 | 0 | 8,452,876 | 0 | |
Seres Therapeutics Inc | COM | 81750R102 | 83,145,838 | 14,664,169 | SH | DFND | 3 | 0 | 14,664,169 | 0 | |
Sigilon Therapeutics Inc | COM | 82657L107 | 8,267,555 | 8,888,888 | SH | DFND | 1,3 | 0 | 8,888,888 | 0 | |
Sigilon Therapeutics Inc | COM | 82657L107 | 1,377,925 | 1,481,481 | SH | DFND | 3 | 0 | 1,481,481 | 0 | |
Syros Pharmaceuticals Inc | COM | 87184Q206 | 784,574 | 293,848 | SH | DFND | 2,3 | 0 | 293,848 | 0 | |
Syros Pharmaceuticals Inc | COM | 87184Q206 | 1,869,000 | 700,000 | SH | DFND | 3 | 0 | 700,000 | 0 |